These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 36011545)

  • 1. Collateral Impact of COVID-19 Prevention Measures on Re-Emergence of Scarlet Fever and Pertussis in Mainland China and Hong Kong China.
    He Y; Ma C; Guo X; Pan J; Xu W; Liu S
    Int J Environ Res Public Health; 2022 Aug; 19(16):. PubMed ID: 36011545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of non-pharmaceutical interventions during COVID-19 pandemic on pertussis, scarlet fever and hand-foot-mouth disease in China.
    Geng Y; Zhang L
    J Infect; 2022 Feb; 84(2):e13-e15. PubMed ID: 34953908
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of meteorological factors on incidence of scarlet fever during different periods in different districts of China.
    Duan Y; Yang LJ; Zhang YJ; Huang XL; Pan GX; Wang J
    Sci Total Environ; 2017 Mar; 581-582():19-24. PubMed ID: 28073056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the impact of COVID-19 non-pharmaceutical interventions and relaxation policies on Class B respiratory infectious diseases transmission in China.
    Wu N; Guan P; An S; Wang Z; Huang D; Ren Y; Wu W
    Sci Rep; 2024 Sep; 14(1):21197. PubMed ID: 39261569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scarlet Fever Epidemic in China Caused by Streptococcus pyogenes Serotype M12: Epidemiologic and Molecular Analysis.
    You Y; Davies MR; Protani M; McIntyre L; Walker MJ; Zhang J
    EBioMedicine; 2018 Feb; 28():128-135. PubMed ID: 29342444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergence of scarlet fever Streptococcus pyogenes emm12 clones in Hong Kong is associated with toxin acquisition and multidrug resistance.
    Davies MR; Holden MT; Coupland P; Chen JH; Venturini C; Barnett TC; Zakour NL; Tse H; Dougan G; Yuen KY; Walker MJ
    Nat Genet; 2015 Jan; 47(1):84-7. PubMed ID: 25401300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of Reemerging Scarlet Fever, Hong Kong, 2005-2015.
    Lee CF; Cowling BJ; Lau EHY
    Emerg Infect Dis; 2017 Oct; 23(10):1707-1710. PubMed ID: 28930009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re-emergence of scarlet fever: old players return?
    Andrey DO; Posfay-Barbe KM
    Expert Rev Anti Infect Ther; 2016 Aug; 14(8):687-9. PubMed ID: 27249582
    [No Abstract]   [Full Text] [Related]  

  • 9. The secondary outcome of public health measures amidst the COVID-19 pandemic in the spread of other respiratory infectious diseases in Thailand.
    Ndeh NT; Tesfaldet YT; Budnard J; Chuaicharoen P
    Travel Med Infect Dis; 2022; 48():102348. PubMed ID: 35523394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiological trend in scarlet fever incidence in China during the COVID-19 pandemic: A time series analysis.
    Ma Y; Gao S; Kang Z; Shan L; Jiao M; Li Y; Liang L; Hao Y; Zhao B; Ning N; Gao L; Cui Y; Sun H; Wu Q; Liu H
    Front Public Health; 2022; 10():923318. PubMed ID: 36589977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scarlet fever outbreak, Hong Kong, 2011.
    Lau EH; Nishiura H; Cowling BJ; Ip DK; Wu JT
    Emerg Infect Dis; 2012 Oct; 18(10):1700-2. PubMed ID: 23017843
    [No Abstract]   [Full Text] [Related]  

  • 12. Resurgence of scarlet fever in China: a 13-year population-based surveillance study.
    Liu Y; Chan TC; Yap LW; Luo Y; Xu W; Qin S; Zhao N; Yu Z; Geng X; Liu SL
    Lancet Infect Dis; 2018 Aug; 18(8):903-912. PubMed ID: 29858148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiological changes of scarlet fever before, during and after the COVID-19 pandemic in Chongqing, China: a 19-year surveillance and prediction study.
    Wu R; Xiong Y; Wang J; Li B; Yang L; Zhao H; Yang J; Yin T; Sun J; Qi L; Long J; Li Q; Zhong X; Tang W; Chen Y; Su K
    BMC Public Health; 2024 Sep; 24(1):2674. PubMed ID: 39350134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiological characteristics of seven notifiable respiratory infectious diseases in the mainland of China: an analysis of national surveillance data from 2017 to 2021.
    Deng LL; Han YJ; Li ZW; Wang DY; Chen T; Ren X; He GX
    Infect Dis Poverty; 2023 Nov; 12(1):99. PubMed ID: 37953290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfer of scarlet fever-associated elements into the group A Streptococcus M1T1 clone.
    Ben Zakour NL; Davies MR; You Y; Chen JH; Forde BM; Stanton-Cook M; Yang R; Cui Y; Barnett TC; Venturini C; Ong CL; Tse H; Dougan G; Zhang J; Yuen KY; Beatson SA; Walker MJ
    Sci Rep; 2015 Nov; 5():15877. PubMed ID: 26522788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic variations in and prediction of COVID-19 with omicron in the four first-tier cities of mainland China, Hong Kong, and Singapore.
    Ni X; Sun B; Hu Z; Cui Q; Zhang Z; Zhang H
    Front Public Health; 2023; 11():1228564. PubMed ID: 37881346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of social and medical portrait of children with pertussis, meningococcal infectious, scarlet fever and estimation of their assigned pharmacotherapy.
    Detsyk O; Fedyak I; Bilyk I
    Wiad Lek; 2019; 72(9 cz 2):1802-1808. PubMed ID: 31622270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scarlet fever epidemic, Hong Kong, 2011.
    Luk EY; Lo JY; Li AZ; Lau MC; Cheung TK; Wong AY; Wong MM; Wong CW; Chuang SK; Tsang T
    Emerg Infect Dis; 2012 Oct; 18(10):1658-61. PubMed ID: 23018120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of toxigenic M1
    Chiang-Ni C; Hsu CY; Yeh YH; Chi CY; Wang S; Tsai PJ; Chiu CH
    J Microbiol Immunol Infect; 2024 Apr; 57(2):269-277. PubMed ID: 38278671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spatial-temporal analysis and visualization of scarlet fever in mainland China from 2004 to 2017.
    Li WT; Feng RH; Li T; Du YB; Zhou N; Hong XQ; Yi SH; Zha WT; Lv Y
    Geospat Health; 2020 Apr; 15(1):. PubMed ID: 32241094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.